Related Experiment Videos
Drug effects on function in the ferret ischemic hindlimb.
1Cardiovascular Pharmacology Department, Bristol-Myers Squibb Co., Wallingford, CT 06492.
Journal of Pharmacological Methods
|July 1, 1990
Summary
A new ferret model for peripheral occlusive arterial disease demonstrates drug efficacy. Pentoxifylline reduced ischemia-induced muscle dysfunction, unlike nifedipine, aiding pharmacotherapy evaluation for vascular diseases.
Area of Science:
- Physiology
- Pharmacology
- Vascular Biology
Background:
- Peripheral occlusive arterial disease (POAD) significantly impacts limb function.
- Existing models may not fully replicate ischemic conditions or allow for controlled pharmacological testing.
- Developing reliable models is crucial for identifying effective treatments for vascular diseases.
Purpose of the Study:
- To introduce and validate a novel animal model for studying peripheral occlusive arterial disease.
- To assess the utility of this model in evaluating potential pharmacotherapies for ischemic conditions.
- To investigate the effects of pentoxifylline and nifedipine on muscle function during induced ischemia.
Main Methods:
- Anesthetized ferret hindlimb preparation with Achilles tendon attached to a force transducer.
- Isometric muscle contraction induced by sciatic nerve stimulation.
- Ischemia induced by partial abdominal aorta occlusion, with controlled femoral perfusion pressure.
Main Results:
- The model demonstrated reproducible muscle contractile force measurements.
- Ischemia significantly reduced muscle function, with a 15-min area under the force-time curve reduced to 33.2% of baseline.
- Pentoxifylline dose-dependently attenuated functional loss, while nifedipine showed no effect.
Conclusions:
- This ferret model provides a controlled environment for evaluating treatments for peripheral vascular diseases.
- The model successfully differentiated the efficacy of pentoxifylline versus nifedipine in an ischemic context.
- It simplifies the assessment of novel pharmacotherapies by minimizing systemic hemodynamic confounding factors.